Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DJ5D4G
|
|||
| Drug Name |
NA-831
|
|||
| Synonyms |
traneurocin
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 3 | [1] | |
| Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7; ICD-9: 331.83] | Phase 2 | [2] | ||
| Company |
NeuroActiva
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04540185) A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT03538522) A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.